News Rezzayo antifungal okayed as Candida auris rings alarm bells Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
News FDA advisors split on Biogen’s ALS therapy But unanimous vote on biomarker validity could support accelerated approval of tofersen.
News Project seeks to shape digital health reimbursement in APAC APACMed and Eversana join forces to draw up coverage frameworks applicable to APAC countries.
News FDA rejects AbbVie’s continuous Parkinson’s therapy Delay could narrow the gap between AbbVie's product and a rival system from Mitsubishi Tanabe.
News Rapid UTI tests could cut antibiotic resistance, says NICE Rapid urine tests could help NHS ensure that antibiotics are used appropriately.
News Sobi plans filings for gout drug after phase 3 readout SEL-212 will compete with Horizon's fast-growing Krystexxa if approved by the FDA.
News Rezzayo antifungal okayed as Candida auris rings alarm bells Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
